RQIK-(Lys-fructosyl)-QTA-(Leu-13C6,15N)-VE (TFA)

RQIK-(Lys-fructosyl)-QTA-(Leu-13C6,15N)-VE (TFA)

• UNSPSC Description: RQIK-(Lys-fructosyl)-QTA-(Leu-13C6,15N)-VE TFA is the 13C and 15N labeled compound[1].
• Target Antigen: Isotope-Labeled Compounds
• Type: Isotope-Labeled Compounds
• Related Pathways: Others
• Field of Research: Others
• Assay Protocol: https://www.medchemexpress.com/rqik-lys-fructosyl-qta-leu-13c6-15n-ve-tfa.html
• Solubility: 10 mM in DMSO
• Smiles: O=C(N[C@@H](CCC(N)=O)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CCCCN)C(N[C@@H](CCCCNCC([C@@H](O)[C@H](O)[C@H](O)CO)=O)C(N[C@@H](CCC(N)=O)C(N[C@@H]([C@H](O)C)C(N[C@@H](C)C(N[13CH]([13CH2][13CH]([13CH3])[13CH3])[13C]([15NH][C@@H](C(C)C)C(N[C@@H](CCC(O)=O)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CCCNC(N)=N)N.OC(C(F)(F)F)=O
• Molecular Weight: 1596.66
• References & Citations: [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported